Associations Between Symptom and Neurocognitive Dimensions in Clinical High Risk for Psychosis

Overview

Journal Schizophr Res Cogn

Specialty Psychology

Date 2022 Jun 9

PMID 35677653

Authors

Ingvild Aase

Johannes H Langeveld

Inge Joa

Jan Olav Johannessen

Ingvild Dalen

Wenche Ten Velden Hegelstad

Affiliations

Soon will be listed here.

Abstract

Introduction: Clinical high risk for psychosis (CHR) is associated with mild cognitive impairments. Symptoms are clustered into positive, negative and disorganization symptoms. The association between specific symptom dimensions and cognitive functions remains unclear. The aim of this study was to investigate the associations between cognitive functions and positive, negative, and disorganization symptoms.

Method: 53 CHR subjects fulfilling criteria for attenuated psychotic syndrome in the Structural Interview for Prodromal Syndromes (SIPS) were assessed for cognitive function. Five cognitive domain z-scores were defined by contrasting with observed scores of a group of healthy controls ( = 40). Principal Components Analyses were performed to construct general cognitive composite scores; one using all subtests and one using the cognitive domains. Associations between cognitive functions and symptoms are presented as Spearman's rank correlations and partial Spearman's rank correlations adjusted for age and gender.

Results: Positive symptoms were negatively associated with executive functions and verbal memory, and disorganization symptoms with poorer verbal fluency. Negative symptoms were associated with better executive functioning. There were no significant associations between the general cognitive composites and any of the symptom domains, except for a trend for positive symptoms.

Conclusion: In line with previous research, data indicated associations between positive symptoms and poorer executive functioning. Negative symptoms may not be related to executive functions in CHR the same way as in psychosis. Our results could indicate that attenuated positive symptoms are more related to cognitive deficits in CHR than positive symptoms in schizophrenia and FEP.

References

Bora E, Murray R . Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?. Schizophr Bull. 2013; 40(4):744-55. PMC: 4059428. DOI: 10.1093/schbul/sbt085. View

Bjornestad J, Tjora T, Langeveld J, Stain H, Joa I, Johannessen J . Exploring specific predictors of psychosis onset over a 2-year period: A decision-tree model. Early Interv Psychiatry. 2021; 16(4):363-370. DOI: 10.1111/eip.13175. View

Sheffield J, Karcher N, Barch D . Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective. Neuropsychol Rev. 2018; 28(4):509-533. PMC: 6475621. DOI: 10.1007/s11065-018-9388-2. View

Guillem F, Rinaldi M, Pampoulova T, Stip E . The complex relationships between executive functions and positive symptoms in schizophrenia. Psychol Med. 2008; 38(6):853-60. DOI: 10.1017/S0033291707002577. View

Mesholam-Gately R, Giuliano A, Goff K, Faraone S, Seidman L . Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009; 23(3):315-36. DOI: 10.1037/a0014708. View

Kirkpatrick B, Fenton W, Carpenter Jr W, Marder S . The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006; 32(2):214-9. PMC: 2632223. DOI: 10.1093/schbul/sbj053. View

Harvey P, Koren D, Reichenberg A, Bowie C . Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr Bull. 2005; 32(2):250-8. PMC: 2632205. DOI: 10.1093/schbul/sbj011. View

Cuesta M, Peralta V . Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res. 1995; 58(3):227-35. DOI: 10.1016/0165-1781(95)02712-6. View

Fuller R, Nopoulos P, Arndt S, OLeary D, Ho B, Andreasen N . Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry. 2002; 159(7):1183-9. DOI: 10.1176/appi.ajp.159.7.1183. View

10.

Lindsberg J, Poutiainen E, Kalska H . Clarifying the diversity of first-episode psychosis: Neuropsychological correlates of clinical symptoms. Nord J Psychiatry. 2009; 63(6):493-500. DOI: 10.3109/08039480903118182. View

11.

Keefe R, Bilder R, Harvey P, Davis S, Palmer B, Gold J . Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006; 31(9):2033-46. DOI: 10.1038/sj.npp.1301072. View

12.

Heinrichs R, Zakzanis K . Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998; 12(3):426-45. DOI: 10.1037//0894-4105.12.3.426. View

13.

Henry J, Crawford J . A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits. Cogn Neuropsychiatry. 2006; 10(1):1-33. DOI: 10.1080/13546800344000309. View

14.

Lam M, Lee J, Rapisarda A, See Y, Yang Z, Lee S . Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis. JAMA Psychiatry. 2018; 75(9):929-939. PMC: 6142925. DOI: 10.1001/jamapsychiatry.2018.1668. View

15.

Loewy R, Fisher M, Schlosser D, Biagianti B, Stuart B, Mathalon D . Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull. 2016; 42 Suppl 1:S118-26. PMC: 4960436. DOI: 10.1093/schbul/sbw009. View

16.

Liu Q, Li C, Wanga V, Shepherd B . Covariate-adjusted Spearman's rank correlation with probability-scale residuals. Biometrics. 2017; 74(2):595-605. PMC: 5949238. DOI: 10.1111/biom.12812. View

17.

Miller T, McGlashan T, Woods S, Stein K, Driesen N, Corcoran C . Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999; 70(4):273-87. DOI: 10.1023/a:1022034115078. View

18.

Rund B, Melle I, Friis S, Larsen T, Midboe L, Opjordsmoen S . Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry. 2004; 161(3):466-72. DOI: 10.1176/appi.ajp.161.3.466. View

19.

Correll C, Schooler N . Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatr Dis Treat. 2020; 16:519-534. PMC: 7041437. DOI: 10.2147/NDT.S225643. View

20.

Hovington C, Bodnar M, Joober R, Malla A, Lepage M . Impairment in verbal memory observed in first episode psychosis patients with persistent negative symptoms. Schizophr Res. 2013; 147(2-3):223-9. DOI: 10.1016/j.schres.2013.04.006. View